Similar articles

• Economic analysis alongside clinical trials: problems and potential.

  Drummond M. Drummond M. J Rheumatol. 1995 Jul;22(7):1403-7. J Rheumatol. 1995. PMID: 7562785 Review.
• Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.

  Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FM Jr, Tsiatis AA, Willan AR, Mark DB, Schulman KA. Reed SD, et al. Am Heart J. 2005 Mar;149(3):434-43. doi: 10.1016/j.ahj.2004.11.001. Am Heart J. 2005. PMID: 15864231
• Problems in interpreting cost effectiveness in clinical trials. Experimental versus implementation costs.

  De Nino LA, Mulrow CD, Gerety MB, Averyt EC. De Nino LA, et al. Online J Curr Clin Trials. 1993 Apr 10;Doc No 44:[4864 words; 42 paragraphs]. Online J Curr Clin Trials. 1993. PMID: 8306003
• Taking quality of life into account in health economic analyses.

  Weeks J. Weeks J. J Natl Cancer Inst Monogr. 1996;(20):23-7. J Natl Cancer Inst Monogr. 1996. PMID: 8750463
• Cost-effectiveness as an outcome in randomized clinical trials.

  Hlatky MA, Owens DK, Sanders GD. Hlatky MA, et al. Clin Trials. 2006;3(6):543-51. doi: 10.1177/1740774506073105. Clin Trials. 2006. PMID: 17170039 Review.